Loading...
PerkinElmer, Inc.
PKI•NYSE
Healthcare
Medical - Diagnostics & Research
$115.24
$-1.06(-0.91%)
PerkinElmer, Inc. (PKI) Financial Performance & Income Statement Overview
Review PerkinElmer, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.16%
↑ 0.16%
Operating Income Growth
15.36%
↑ 15.36%
Net Income Growth
-60.99%
↓ 60.99%
Operating Cash Flow Growth
588.38%
↑ 588.38%
Operating Margin
12.65%
↑ 12.65%
Gross Margin
63.97%
↑ 63.97%
Net Profit Margin
11.03%
↑ 11.03%
ROE
3.79%
↑ 3.79%
ROIC
2.89%
↑ 2.89%
PerkinElmer, Inc. (PKI) Income Statement & Financial Overview
Review PerkinElmer, Inc.'s (PKI) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $729.37M | $684.05M | $691.68M | $649.92M |
| Cost of Revenue | $317.08M | $299.23M | $306.18M | $386.11M |
| Gross Profit | $412.29M | $384.82M | $385.51M | $263.81M |
| Gross Profit Ratio | $0.57 | $0.56 | $0.56 | $0.41 |
| R&D Expenses | $49.21M | $49.14M | $48.13M | $50.36M |
| SG&A Expenses | $245.04M | $239.48M | $235.85M | $169.33M |
| Operating Expenses | $293.54M | $286.67M | $283.98M | $219.69M |
| Total Costs & Expenses | $610.62M | $585.90M | $590.16M | $605.80M |
| Interest Income | $9.83M | $22.76M | $20.51M | $20.09M |
| Interest Expense | $22.78M | $24.38M | $24.72M | $24.40M |
| Depreciation & Amortization | $105.03M | $107.67M | $107.24M | $107.80M |
| EBITDA | $223.07M | $232.41M | $218.62M | $180.89M |
| EBITDA Ratio | $0.31 | $0.34 | $0.30 | $0.23 |
| Operating Income | $118.75M | $98.15M | $101.52M | $44.12M |
| Operating Income Ratio | $0.16 | $0.14 | $0.15 | $0.07 |
| Other Income/Expenses (Net) | -$24.19M | $2.21M | $938000.00 | -$9.57M |
| Income Before Tax | $94.56M | $100.36M | $86.66M | $34.55M |
| Income Before Tax Ratio | $0.13 | $0.15 | $0.13 | $0.05 |
| Income Tax Expense | $6.17M | $6.97M | $14.06M | $5.85M |
| Net Income | $94.64M | $93.39M | $79.11M | $26.01M |
| Net Income Ratio | $0.13 | $0.14 | $0.11 | $0.04 |
| EPS | -$1.35 | $0.77 | $0.64 | $0.21 |
| Diluted EPS | -$1.45 | $0.77 | $0.64 | $0.23 |
| Weighted Avg Shares Outstanding | $130.20M | $122.81M | $123.35M | $123.43M |
| Weighted Avg Shares Outstanding (Diluted) | $121.58M | $123.03M | $123.48M | $123.54M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan